Back to Search
Start Over
Vaxxas Appoints Leading Global Vaccine Experts as the Company Advances its Needle-Free Vaccination Technology Towards Late-Stage Clinical Trials
- Source :
- Business Wire. February 5, 2025
- Publication Year :
- 2025
-
Abstract
- BRISBANE, Australia & CAMBRIDGE, Mass. -- Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.826259885